Synonyms: APO-66 | CP20 | Ferriprox®
deferiprone is an approved drug (EMA (1999), FDA (2011))
Compound class:
Synthetic organic
Comment: Deferiprone is an iron-chelating drug.
|
|
No information available. |
Summary of Clinical Use ![]() |
Patients with thalassaemia often require repeated blood transfusions to maintain red blood cell levels, but this type of treatment can lead to potentially fatal iron overload. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
Deferiprone chelates the excess iron in thalassemia patients [1], and effects its removal and excretion. |
External links ![]() |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com European Medicines Agency (EMA) |